Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback